{
Stevanto

Companies

}
001122334455554433221100
001122334455554433221100

UBS maintains buy rating for Gerresheimer with target price of 132 euros

UBS has maintained a "Buy" rating for Gerresheimer, setting a target price of 132 euros. Analyst Olivier Calvet highlighted that data on Novo Nordisk's weight-loss drug CagriSema could significantly impact Gerresheimer, positioning it favorably against competitors like Ypsomed.
boerse.de
Euro Gerresheimer AG Stevanto UBS Novo Nordisk A/S SCHOTT Pharma AG & Co. KGaA I Ypsomed Holding AG DEU Olivier Calvet Show more
TradFi, Market Report
10:48 29.11.2024

ubs maintains buy rating on gerresheimer with target of 132 euros

UBS has maintained a Buy recommendation for Gerresheimer, setting a price target of 132 euros. Analyst Olivier Calvet notes that data from the study on Novo Nordisk's weight-lowering drug CagriSema could significantly impact the company's stock, as Gerresheimer is a key supplier.
Zonebourse
Euro Gerresheimer AG Stevanto UBS Novo Nordisk A/S SCHOTT Pharma AG & Co. KGaA I Ypsomed Holding AG DEU Olivier Calvet Show more
TradFi, Market Report
09:48 29.11.2024

ubs maintains buy rating for gerresheimer with target price of 132 euros

UBS has maintained a "Buy" rating for Gerresheimer, setting a target price of 132 euros. Analyst Olivier Calvet highlighted that data from Novo Nordisk's weight-loss drug CagriSema could significantly impact Gerresheimer, positioning it favorably against competitors like Ypsomed.
@borsen_news
Euro Gerresheimer AG Stevanto UBS Novo Nordisk A/S SCHOTT Pharma AG & Co. KGaA I Ypsomed Holding AG DEU Olivier Calvet Show more
TradFi, Market Report
08:49 29.11.2024

ubs maintains buy rating for gerresheimer with target price of 132 euros

UBS has maintained its "Buy" rating for Gerresheimer, setting a target price of 132 euros. Analyst Olivier Calvet noted that study data on Novo Nordisk's weight-loss drug CagriSema could significantly impact Gerresheimer, positioning it favorably against competitors like Ypsomed.
boerse.de
Euro Gerresheimer AG Stevanto UBS Novo Nordisk A/S SCHOTT Pharma AG & Co. KGaA I Ypsomed Holding AG CHE Olivier Calvet Show more
TradFi, Market Report
08:04 29.11.2024

ubs maintains buy rating for gerresheimer with target price of 132 euros

UBS has maintained a 'Buy' rating for Gerresheimer, setting a target price of 132 euros. Analyst Olivier Calvet noted that data from Novo Nordisk's weight-lowering drug CagriSema could positively impact Gerresheimer, positioning it favorably compared to Ypsomed. Schott Pharma and Stevanto remain unaffected.
MarketScreener
Euro Gerresheimer AG Stevanto UBS Novo Nordisk A/S SCHOTT Pharma AG & Co. KGaA Ypsomed Holding AG DEU Olivier Calvet Show more
TradFi, Market Report
07:51 29.11.2024

ubs upgrades gerresheimer to buy with target price of 132 euros

UBS has upgraded Gerresheimer to a 'Buy' rating with a target price of 132 euros. Analyst Olivier Calvet noted that data from Novo Nordisk's weight-lowering drug CagriSema could significantly impact Gerresheimer, positioning it favorably compared to competitors like Ypsomed.
aktiencheck.de
Euro Gerresheimer AG Stevanto UBS Novo Nordisk A/S SCHOTT Pharma AG & Co. KGaA Ypsomed Holding AG CHE Olivier Calvet Show more
TradFi, Market Report
07:04 29.11.2024
Trending
Subcategory
Industry Trends Corporate News Startups & Entrepreneurship Retail and Consumer Goods Supply Chain Management Global Trade Developments Workplace Trends Government Economic Policies Stock Market Updates Industry Mergers & Acquisitions CEO Changes Venture Capital Investments Finance Mergers & Acquisitions Fintech Startups Financial Scams and Security Cryptocurrency & Blockchain Regulations Energy Sector Developments Emerging Startups Cryptocurrency Trends Funding Rounds & Investments
Countries:
USA CHN IND ARE JPN KOR SAU AUS HKG SGP VNM IDN GBR ISR MAR DEU NLD MYS PHL TWN
Companies:
Apple Inc. Google Inc. Alphabet Inc. NVIDIA Corporation Tesla, Inc. Microsoft Corporation Amazon.com, Inc. Delhivery Limited Ecom Express Ltd. Foxconn Technology Co., Ltd. Samsung SDI Co., Ltd. SWIGGY LIMITED UWS JP Morgan EM A OSB Netflix, Inc. Airbnb, Inc. Adobe Inc. GEELY AUTO TENCENT CarTrade Tech Limited Ciscom Corp.
Currencies:
United States Dollar Chinese Yuan Indian Rupee Euro Japanese Yen South Korean Won Vietnamese Đồng Indonesian Rupiah Algerian Dinar Australian Dollar Egyptian Pound Saudi Riyal Swiss Franc British Pound Sterling Russian Ruble
People:
Donald Trump Elon Musk Ursula von der Leyen Tim Cook Xi Jinping Sri Mulyani Willson Cuaca Scott Bessent Mohammed bin Zayed Al Nahyan Saint Peter Noureddine Ouadah Imad Boumahdi Peter Thiel Ilya Sutskever Trixie Lohmirmand James Luo Charles Kao Karim Shehata Mark Carney Howard Lutnick

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.